Arxis, Inc.
For the period ended Sep 30, 2026. Filed Oct 29, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Oct 29, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Comprehensive Income (Loss)
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| 2026 | 2025 | 2026 | 2025 | |
| Net income (loss) | $83,713 | $(10,097) | $132,113 | $(43,677) |
| Other comprehensive income (loss), net of tax: | ||||
| Foreign currency translation gain (loss) | (2,055) | (6,651) | (20,853) | 42,467 |
| Actuarial gain (loss) related to defined benefit pension plans | (5) | — | (16) | — |
| Other comprehensive income (loss) | (2,060) | (6,651) | (20,869) | 42,467 |
| Total comprehensive income (loss), net of tax | $81,653 | $(16,748) | $111,244 | $(1,210) |
Condensed Consolidated Statements of Stockholders' and Members' Equity
| Common Stock | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Members’ Equity · Shares · Amount · Treasury Stock · Additional Paid-In Capital · Retained Earnings (Accumulated Deficit) · Accumulated Other Comprehensive Income (Loss) · Total Stockholders' Equity | ||||||||||||||||
| Balance as of December 31, 2025 | $3,124,058 | — | $— | $— | $— | $— | $— | $3,124,058 | ||||||||
| Net income | 53,309 | — | — | — | — | — | — | 53,309 | ||||||||
| Other comprehensive loss | (15,033) | — | — | — | — | — | — | (15,033) | ||||||||
| Issuance of members’ units | 2,500 | — | — | — | — | — | — | 2,500 | ||||||||
| Settlement of notes receivable(1) | 4,361 | — | — | — | — | — | — | 4,361 | ||||||||
| Contributions | 11,344 | — | — | — | — | — | — | 11,344 | ||||||||
| Distributions | (307) | — | — | — | — | — | — | (307) | ||||||||
| Share-based compensation | 3,042 | — | — | — | — | — | — | 3,042 | ||||||||
| Balance as of March 31, 2026 | 3,183,274 | — | — | — | — | — | — | 3,183,274 | ||||||||
| Effect of the Reorganization(2) | (3,183,274) | 371,807 | 3,718 | — | 3,257,762 | (11,203) | 5,651 | 72,654 | ||||||||
| Common stock withheld related to net share settlement of equity awards | — | — | — | (34,639) | — | — | — | (34,639) | ||||||||
| Issuance of common stock sold in initial public offering, net of offering costs | — | 46,575 | 466 | — | 1,227,287 | — | — | 1,227,753 | ||||||||
| Net loss | — | — | — | — | — | (4,909) | — | (4,909) | ||||||||
| Other comprehensive loss | — | — | — | — | — | — | (3,776) | (3,776) | ||||||||
| Issuance of common stock under share-based arrangements | — | 8 | — | — | — | — | — | — | ||||||||
| Settlement of notes receivable(1) | — | — | — | — | 1,065 | — | — | 1,065 | ||||||||
| Share-based compensation | — | — | — | — | 26,136 | — | — | 26,136 | ||||||||
| Balance as of June 30, 2026 | $— | 418,390 | 4,184 | (34,639) | 4,512,250 | (16,112) | 1,875 | $4,467,558 | ||||||||
| Net income (loss) | — | — | — | — | — | 83,713 | — | 83,713 | ||||||||
| Other comprehensive income (loss) | — | — | — | — | — | — | (2,060) | (2,060) | ||||||||
| Settlement of notes receivable(1) | — | — | — | — | 1,050 | — | — | 1,050 | ||||||||
| Issuance of common stock as consideration for Omnetics Merger | — | 13,352 | 134 | — | 768,939 | — | — | 769,073 | ||||||||
| Cancellation of common stock and adjustment to common stock withheld related to net share settlement of equity awards | (8) | — | (77) | — | — | — | (77) | |||||||||
| Share-based compensation | — | — | — | — | 30,731 | — | — | 30,731 | ||||||||
| Balance as of September 30, 2026 | $— | 431,733 | (3) | $4,318 | $(34,716) | $5,312,970 | $67,601 | $(185) | $5,349,988 | |||||||
(1)
(2)
Includes share-based compensation related to the modified equity awards as a result of the Reorganization. See "Note 15. Share-Based Arrangements" for further details.
(3)
Includes 7,458 restricted shares of common stock held by employees that remain subject to forfeiture based on time-based vesting conditions. See "Note 14. Equity" and "Note 15. Share-Based Arrangements" for further details.
Condensed Consolidated Statements of Stockholders' and Members' Equity
| Members’ Equity | |
|---|---|
| Balance as of December 31, 2024 | $2,977,127 |
| Net loss | (4,324) |
| Other comprehensive income | 17,987 |
| Issuance of notes receivable(1) | (3,000) |
| Contributions | 385,000 |
| Distributions | (350,257) |
| Share-based compensation | 2,330 |
| Balance as of March 31, 2025 | 3,024,863 |
| Net loss | (29,256) |
| Other comprehensive income | 31,131 |
| Distributions | (862) |
| Share-based compensation | 2,206 |
| Balance as of June 30, 2025 | $3,028,082 |
| Net loss | (10,097) |
| Other comprehensive income (loss) | (6,651) |
| Issuance of members’ units | 10,851 |
| Issuance of notes receivable(1) | (3,500) |
| Distributions | (11,210) |
| Share-based compensation | 4,789 |
| Balance as of September 30, 2025 | $3,012,264 |
(1)
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.